Onureg 200 mg (Azacitidine TABLET) 200 MG

ONUREG 200 MG tablets contain azacitidine, a medication used in managing certain blood disorders. This oral formulation is designed for specific therapeutic applications, offering a convenient alternative to injectable forms.

Strength

200 MG

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONUREG 200 MG tablets are primarily used in the treatment of myelodysplastic syndromes (MDS), a group of conditions where the bone marrow does not produce enough healthy blood cells. This medication works by helping the bone marrow produce normal blood cells. Patients often wonder, 'What is ONUREG used for?' and the answer lies in its role in managing these specific blood disorders.

Side Effects

Common effects of ONUREG 200 MG tablets may include fatigue, nausea, and injection site reactions. Some users may experience changes in blood cell counts, which is why regular monitoring is often recommended. These effects can vary from person to person, and not everyone will experience them.

Precautions & Warnings

ONUREG 200 MG tablets should be handled with care, as they are intended for specific medical uses. It is important to follow the advice of a healthcare provider regarding storage and administration. Pregnant women or those planning to become pregnant should discuss the use of this medication with their healthcare provider.

Avoid Interactions

ONUREG 200 MG tablets may interact with other medications, including those that affect the immune system or blood cell production. Alcohol and certain supplements may also interact with this medication. It is advisable to inform your healthcare provider about all medications and supplements you are taking before starting ONUREG.

Frequently Asked Questions

ONUREG 200 MG tablets are used in the treatment of myelodysplastic syndromes (MDS), helping the bone marrow produce normal blood cells.

ONUREG 200 MG tablets are taken orally, typically under the guidance of a healthcare provider.

Common side effects may include fatigue, nausea, and changes in blood cell counts.

ONUREG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Pregnant women or those planning to become pregnant should discuss the use of ONUREG with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.